Stretch Marks (Striae Distensae): What Research Shows About Dermal Remodelling and Where Peptides Fit
Stretch marks are dermal scars formed when the skin's collagen and elastin network is stretched or disrupted faster than it can adapt. This article reviews what is known about how striae form, why they are hard to treat, and what preclinical research suggests about peptides and dermal remodelling.
By UAE Peptide Clinic Research Desk
Stretch marks, known clinically as striae distensae, are among the most common skin changes seen in adults. They appear after pregnancy, rapid weight gain or loss, adolescent growth spurts, intensive resistance training and prolonged use of topical or systemic corticosteroids. Although harmless medically, they are a frequent source of concern, and they are notoriously difficult to treat once established. Understanding what is happening in the skin helps explain why, and where emerging peptide research may be relevant.
What happens in the dermis
Striae are best understood as a form of dermal scarring. The dermis is a network of collagen and elastin fibres produced by fibroblasts, and it gives skin both its strength and its ability to recoil. When the skin is stretched quickly, or when hormonal signals such as raised cortisol weaken fibroblast activity, this network can tear or thin. Histological studies describe early striae as red or purple (striae rubrae), with inflammation and dilated blood vessels, and older striae as pale or silvery (striae albae), with a flattened epidermis and sparse, disorganised collagen.
This distinction matters. Research suggests that early lesions still have an active inflammatory and vascular component, whereas mature lesions resemble atrophic scar tissue with reduced elastin. Most clinical interest has therefore focused on the early stage, when the tissue is still remodelling.
Striae are not a surface problem. They are a change in the architecture of the dermis, which is why creams alone have shown limited results.
Why they are hard to treat
Published trials of topical products, including retinoids, centella-based preparations and hyaluronic acid, report modest and inconsistent improvements, and study quality is often limited by small samples and short follow-up. Procedural approaches such as fractional laser, microneedling and radiofrequency have more consistent data, particularly for texture and colour, but results vary with skin type and lesion age. In the UAE, where many residents have higher baseline pigmentation and high sun exposure, treatment planning also needs to account for the risk of post-inflammatory hyperpigmentation.
- Lesion age: early red striae generally respond better than mature white ones
- Skin phototype: darker skin carries a higher risk of pigment change after energy-based procedures
- Cause: striae linked to corticosteroid exposure or hormonal conditions need the underlying driver reviewed first
- Sun exposure: unprotected UV can accentuate contrast between striae and surrounding skin
Where peptide research fits
Several peptides have been studied for their effects on fibroblast behaviour and extracellular matrix turnover. GHK-Cu, a naturally occurring copper-binding tripeptide, has been examined in laboratory and small human studies for its association with increased collagen and glycosaminoglycan synthesis and with modulation of matrix metalloproteinases, the enzymes involved in tissue breakdown and remodelling. These findings are largely preclinical or drawn from cosmetic studies on photoageing and wound healing, not from trials in striae specifically.
Other repair-oriented peptides, including BPC-157 and thymosin beta-4 fragments, have preclinical data on angiogenesis and tissue repair in tendon, gut and wound models. Whether any of this translates to dermal remodelling in established stretch marks has not been demonstrated in controlled human trials. It is therefore more accurate to describe these peptides as areas of research interest than as established treatments for striae.
Clinical nuance
Any peptide discussion sits alongside a physician review. Rapid weight change, steroid exposure, endocrine conditions such as Cushing's syndrome and nutritional status can all influence how skin remodels. A sensible assessment considers these factors, along with realistic expectations: the evidence supports improvement in appearance for some people, not complete resolution.
If you're exploring stretch marks and dermal remodelling as part of your protocol, our clinical team can review your case — take the 2-minute quiz at /find-my-stack or book a free consultation at /book.
